RxDoctor Payments Data

Bohdan Warycha, MD

Pain Medicine · Middlebury, CTNPI 1154580827

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Boston Scientific at 30.1% of the total. Reporting peaked in 2019 at $944 and has fallen 61.6% since, to $362 in 2025.

$2,832in general payments, 2019–2025

Across 85 payments — averaging $33.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$852
  • AbbVie$650
  • SPR Therapeutics, Inc$444
  • Bioventus LLC$178
  • Si-bone, Inc.$154
  • Medtronic$99
  • plus $455 from 13 others

What the payments were for

  • Food & beverage$2,832100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,832 in reported general payments places this provider in the 60th percentile of 69 pain medicine providers in Connecticut.

See all pain medicine providers in Connecticut

Medicare billing

Part B allowed, 2024
$180,767
Medicare patients
243
Services billed
5,977

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PercocetOxycodone Hcl/Acetaminophen18$64,290
Oxycodone Hcl84$1,619
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen80$1,574
Gabapentin60$1,072
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen65$1,045
Fentanyl14$957
Pregabalin56$905
Morphine Sulfate ErMorphine Sulfate19$407
Tizanidine Hcl47$310
Cyclobenzaprine Hcl25$281
Tramadol Hcl68$236
Acetaminophen-CodeineAcetaminophen With Codeine14$163
Ibuprofen18$123
Carisoprodol12$115
Methocarbamol12$94

Paid to pharmacies, not to this prescriber.

Other pain medicine in Middlebury

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →